Pharmacy & Pharmaceutical Sciences / Plasma Protein Binding Assay
FREE TO EXPLORE
LABORATORY 18 · PHARMACY & PHARMACEUTICAL SCIENCES

Equilibrium Dialysis Determination of Free Fraction & Human Serum Albumin Binding

Measure the unbound active drug fraction (fu) and association constant (Ka) of warfarin binding to human serum albumin (HSA) using semi-permeable equilibrium dialysis. Explore interactive pharmaceutical simulation, formulation physics, and analytical assays.

PHARMACY & PHARMACEUTICAL SCIENCES · PHARMACEUTICS · ANALYSIS · PHARMACOKINETICS · PHARMACOLOGY

Your virtual pharmacy & pharmaceutical sciences laboratory.

UNBOUND DIALYSATE DRUG CONCENTRATION—
CALIBRATED PHARMACEUTICAL TELEMETRY

Ready to sample with Total Drug Conc = 5.0 μg/mL.

5.0 μg/mL
Standardized USP / Ph. Eur. pharmaceutical testing protocol.

Adjust Total Drug Conc, then execute analytical assay.

Active pharmaceutical ingredient (API) concentration and physicochemical telemetry are recorded using high-precision digital instrumentation and 64-bit IEEE 754 floating-point logging under temperature-controlled laboratory conditions. Residuals reflect ordinary least-squares regression across successive observations. Continuous data structures support comprehensive pharmaceutics, analytical, and pharmacokinetic evaluation.

Pharmaceutical constitutive model and compendial boundary limits

All pharmaceutical assays, dissolution profiles, and pharmacokinetic parameters are evaluated under standardized USP and ICH laboratory protocols. Linear constitutive models reflect small-perturbation concentrations, stoichiometric reactions, and standard calibration limits.

Laboratory apparatus & testing equipment.

96-Well Teflon Rapid Equilibrium Dialysis (RED) Device

Primary standardized university-grade instrument delivering calibrated, traceable measurements for Plasma Protein Binding Assay protocols.

Regenerated Cellulose Dialysis Membranes (MWCO 8,000–10,000 Da)

Essential secondary analytical hardware maintaining environmental, photometric, or mechanical equilibrium during Plasma Protein Binding Assay procedures.

Precision Thermostatted Microplate Shaker (37.0 ± 0.5 °C)

Specialized sample holding vessel, reaction column, or sensor cell eliminating matrix artifacts.

LC-MS/MS Triple Quadrupole Tandem Mass Spectrometer

High-precision digital telemetry recording interface capturing 64-bit real-time analytical readings in accordance with pharmacopoeial standards.

Lyophilized Fatty-Acid-Free Human Serum Albumin Reagent

Analytical reagent grade reference standard or carrier fluid ensuring calibration traceability.

Phosphate-Buffered Saline Solution (pH 7.40 ± 0.02)

Precision measurement tool verifying transducer zero-drift and alignment prior to analytical testing.

FOLLOW THE METHOD

A reason behind every step.

Measure the unbound active drug fraction (fu) and association constant (Ka) of warfarin binding to human serum albumin (HSA) using semi-permeable equilibrium dialysis. Standardized parameter settings: 1.0, 2.8, 4.6, 6.4, 8.2, 10.0 μg/mL.

  1. Step 1

    Instrument Initialization & Baseline Tare

    Power on the analytical instrumentation for Plasma Protein Binding Assay, allow a 30-minute electronic warm-up period, and verify transducer zero-tare using certified standards.

  2. Step 2

    Standard Solution & Matrix Specimen Preparation

    Accurately compound, dilute, or compress active pharmaceutical ingredient (API) specimens under strictly regulated environmental conditions (25.0 ± 0.5 °C).

  3. Step 3

    Systematic Independent Variable Setting

    Adjust the independent testing parameter (Total Drug Conc) across the designated analytical range (1.0 to 10.0 μg/mL) in uniform calibrated steps.

  4. Step 4

    Analytical Signal Acquisition & Telemetry Logging

    Execute the measurement cycle and record steady-state telemetry for Unbound Dialysate Drug Concentration with high-precision digital integration.

  5. Step 5

    Replicate Verification & Equilibrium Inspection

    Perform triplicate test acquisitions at each testing setpoint to verify signal stability, absence of thermal drift, and sample reproducibility.

  6. Step 6

    Regression Modeling & Pharmacopoeial Parameter Derivation

    Plot Total Drug Conc (μg/mL) against Free Drug Conc (μg/mL), execute ordinary least-squares (OLS) linear regression, and calculate Unbound Free Drug Fraction (fu) (fu) against compendial benchmarks.

YOUR NOTEBOOK · 0 OBSERVATIONS

Turn measurements into pharmaceutical insight.

See a complete example report ↗

Points are your recorded observations. The solid regression line validates Plasma Protein Binding Assay mathematical scaling.

LINEAR REGRESSION FIT · y = mx + b
Free Unbound Conc (μg/mL) = 0.0125 · Total Conc (μg/mL) + 0.0020
#Total System Drug Concentration (μg/mL)Unbound Dialysate Drug Concentration (μg/mL)Total Drug Conc (μg/mL)Free Drug Conc (μg/mL)

No readings yet. Execute an analytical assay and record it.

CHECK YOUR UNDERSTANDING

Explain what the pharmaceutical metrics mean.

Question 1: The primary physicochemical principle investigated in Plasma Protein Binding Assay is:

Question 2: In the evaluation of Plasma Protein Binding Assay, increasing Total Drug Conc results in:

Question 3: Which regulatory compendium defines official testing specifications for Plasma Protein Binding Assay?

Question 4: Ordinary least-squares (OLS) regression in Plasma Protein Binding Assay is utilized to:

THEORY AND CLINICAL CONTEXT

Pharmacy & Pharmaceutical Sciences background & chemical principles.

Measure the unbound active drug fraction (fu) and association constant (Ka) of warfarin binding to human serum albumin (HSA) using semi-permeable equilibrium dialysis.

Free Unbound Conc (μg/mL) = 0.0125 · Total Conc (μg/mL) + 0.0020

Pharmaceutical science principles integrate medicinal chemistry, physical pharmaceutics, dosage form technology, and clinical pharmacokinetics into rigorous quantitative frameworks.